Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Antibody-Drug Conjugates for Breast Cancer | Faculty Presentation 2: Current and Emerging Role of TROP2-Directed ADCs — Sara M Tolaney, MD, MPH
Antibody-Drug Conjugates for Breast Cancer | Sara M Tolaney, MD, MPH
Posted on 03/01/2026